PankoMab-GEX™: Phase 1 Dose Escalation Study
Clinical trial NCT01222624 · COMPLETED
Trial details
- NCT number
- NCT01222624
- Sponsor
- Glycotope GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2012-12-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.